| Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries | Ca-A Cancer Journal for Clinicians | 2021 | 11.2K |
| Dexamethasone in Hospitalized Patients with Covid-19 | New England Journal of Medicine | 2021 | 4.4K |
| Cancer Statistics, 2021 | Ca-A Cancer Journal for Clinicians | 2021 | 4K |
| Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine | New England Journal of Medicine | 2021 | 3.7K |
| Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK | Lancet, The | 2021 | 2.1K |
| 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC | European Heart Journal | 2021 | 1.7K |
| 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study | Lancet, The | 2021 | 1.3K |
| Characteristics of SARS-CoV-2 and COVID-19 | Nature Reviews Microbiology | 2021 | 1.3K |
| Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results | New England Journal of Medicine | 2021 | 1.2K |
| BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting | New England Journal of Medicine | 2021 | 1.1K |
| Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection | Nature Medicine | 2021 | 1.1K |
| Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association | Circulation | 2021 | 1.1K |
| Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant | New England Journal of Medicine | 2021 | 1.1K |
| Post-acute COVID-19 syndrome | Nature Medicine | 2021 | 976 |
| A global survey of potential acceptance of a COVID-19 vaccine | Nature Medicine | 2021 | 948 |
| Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination | New England Journal of Medicine | 2021 | 940 |
| 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation | European Heart Journal | 2021 | 920 |
| 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure | European Heart Journal | 2021 | 875 |
| SARS-CoV-2 variants, spike mutations and immune escape | Nature Reviews Microbiology | 2021 | 873 |
| Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19 | New England Journal of Medicine | 2021 | 865 |
| Coronavirus biology and replication: implications for SARS-CoV-2 | Nature Reviews Microbiology | 2021 | 830 |
| Engineering precision nanoparticles for drug delivery | Nature Reviews Drug Discovery | 2021 | 822 |
| REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19 | New England Journal of Medicine | 2021 | 810 |
| Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia | Lancet, The | 2021 | 745 |
| SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19 | New England Journal of Medicine | 2021 | 717 |
